Merck faces first of nearly 1,000 Fosamax lawsuits today

It's about allegations that the osteoporosis drug resulted in injury to jawbone tissue.

Bloomberg reports:

The trial in New York of the first case of the group, filed by Shirley Boles, 71, will be one of three so-called bellwether cases that may point the way to out-of-court settlements.

"In mass litigation, all eyes are on the first trial, not only because it shows the strategy of each side, but also because it's the first information about how jurors respond to the evidence," said Howard Erichson, a law professor at Fordham University in New York and an expert on civil procedure.


There are as many as 1,200 plaintiffs in state and federal cases, Merck says. Timothy O'Brien, a lawyer representing about 400 plaintiffs, said the number is closer to 2,000.

About this Entry

This page contains a single entry by Gary Schwitzer published on August 11, 2009 8:35 AM.

Well-known people sharing cancer diagnoses & non-evidence-based advice was the previous entry in this blog.

Disease-mongering PR tactics, part two is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.



Wikio - Top of the Blogs - Health

Add to Technorati Favorites